Shares of Viatris Inc. VTRS advanced 1.72% to $11.25 Friday, on what proved to be an all-around rough trading session for the ...

Viatris VTRS, a global healthcare company, is scheduled to report fourth-quarter and full-year 2024 results on Feb. 27, 2025.

The end of the earnings season is always a good time to take a step back and see who shined (and who not so much). Let’s take ...

Shares of Viatris Inc. VTRS advanced 1.19% to $11.06 Thursday, on what proved to be an all-around dismal trading session for ...

Siddiq, Biotricity Founder & CEO, said, “In the third quarter of fiscal 2025, we continued our mission to innovate a ...

Reports Q4 revenue EUR65.68M from EUR65.30M last year. CEO Brigitte de Vet-Veithen commented, “In the final quarter of 2024 our Materialise ...